Table 2.
Variable | Disease-free survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
P-value | Hazard ratio | 95% CI | P-value | P-value | Hazard ratio | 95% CI | P-value | |
Age | 0.76 | 0.93 | 0.29–2.24 | 0.71 | 0.62 | 1.21 | 0.31–2.36 | 0.66 |
Menopausal status | 0.35 | 1.11 | 0.26–3.12 | 0.38 | 0.29 | 1.38 | 0.47–3.11 | 0.32 |
TNM stage | 0.07 | 2.38 | 0.92–6.77 | 0.06 | 0.04 | 3.31 | 1.38–7.29 | 0.02 |
Grade | 0.01 | 3.19 | 2.13–10.02 | 0.003 | 0.08 | 2.39 | 0.87–6.32 | 0.09 |
Histological type | 0.12 | 0.79 | 0.23–3.19 | 0.24 | 0.33 | 1.28 | 0.38–3.03 | 0.67 |
Lymphonodus status | 0.03 | 4.12 | 1.98–15.21 | 0.007 | 0.009 | 2.98 | 1.86–10.02 | 0.012 |
ER status | 0.34 | 1.67 | 0.57–2.78 | 0.18 | 0.19 | 1.39 | 0.38–2.93 | 0.31 |
PR status | 0.38 | 1.93 | 0.78–3.19 | 0.21 | 0.27 | 1.71 | 0.27–3.12 | 0.29 |
HER2 status | 0.41 | 1.98 | 0.68–2.99 | 0.19 | 0.32 | 1.38 | 0.82–3.58 | 0.11 |
Serum soluble E-cad level | 0.01 | 3.38 | 2.47–11.89 | 0.009 | 0.03 | 2.97 | 1.28–9.11 | 0.017 |